ARISE study: Study Design and Baseline Characteristics for a Phase 2 Trial of the Anti-Tau Antibody ABBV-8E12 in Progressive Supranuclear Palsy - MDS Abstracts
![Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson's Disease | The Journal of Neuropsychiatry and Clinical Neurosciences Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson's Disease | The Journal of Neuropsychiatry and Clinical Neurosciences](https://neuro.psychiatryonline.org/cms/10.1176/jnp.13.1.42/asset/images/medium/a5z14435t1.jpeg)
Neuropsychiatric Symptoms of Patients With Progressive Supranuclear Palsy and Parkinson's Disease | The Journal of Neuropsychiatry and Clinical Neurosciences
Clinical Correlates of Genetic and Biomarker Profiles in Patients with Progressive Supranuclear Palsy: Data from the ARISE Study - MDS Abstracts
UCLA Neurology on Twitter: "Pseudoprogression shows early radiographic progression followed by stability or regression. This @JNeurooncol study with Dr. Timothy Cloughesy shows patients with “clinically-defined PsP” have distinct characteristics, which ...
Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE | PLOS ONE
![Characteristics of PSP cohort including demographics, probability of... | Download Scientific Diagram Characteristics of PSP cohort including demographics, probability of... | Download Scientific Diagram](https://www.researchgate.net/publication/335080324/figure/tbl1/AS:790043669037057@1565372497956/Characteristics-of-PSP-cohort-including-demographics-probability-of-diagnosis-using.png)